These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 27662822

  • 1. The anti-adipogenic effect of peripheral blood mononuclear cells is absent with PCSK9 loss-of-function variants.
    Gagnon A, Ooi TC, Cousins M, Favreau C, Henry K, Landry A, Sorisky A.
    Obesity (Silver Spring); 2016 Nov; 24(11):2384-2391. PubMed ID: 27662822
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The impact of the PCSK-9/VLDL-Receptor axis on inflammatory cell polarization.
    Barcena ML, Estepa M, Marx L, Breiter A, Haritonow N, Stawowy P.
    Cytokine; 2023 Jan; 161():156077. PubMed ID: 36356495
    [Abstract] [Full Text] [Related]

  • 4. Impact of PCSK9 loss-of-function genotype on 1-year mortality and recurrent infection in sepsis survivors.
    Genga KR, Lo C, Cirstea MS, Leitao Filho FS, Walley KR, Russell JA, Linder A, Francis GA, Boyd JH.
    EBioMedicine; 2018 Dec; 38():257-264. PubMed ID: 30473376
    [Abstract] [Full Text] [Related]

  • 5. Predicting proprotein convertase subtilisin kexin type-9 loss of function mutations using plasma PCSK9 concentration.
    Wanneh E, Luna G, Dufour R, Baass A.
    J Clin Lipidol; 2017 Dec; 11(1):55-60. PubMed ID: 28391911
    [Abstract] [Full Text] [Related]

  • 6. α-Linolenic acid increases the G0/G1 switch gene 2 mRNA expression in peripheral blood mononuclear cells from obese patients: a pilot study.
    Zhao N, Wang L, Guo N.
    Lipids Health Dis; 2016 Feb 24; 15():36. PubMed ID: 26912161
    [Abstract] [Full Text] [Related]

  • 7. Thyroid stimulating hormone exhibits the impact on LDLR/LDL-c via up-regulating hepatic PCSK9 expression.
    Gong Y, Ma Y, Ye Z, Fu Z, Yang P, Gao B, Guo W, Hu D, Ye J, Ma S, Zhang F, Zhou L, Xu X, Li Z, Yang T, Zhou H.
    Metabolism; 2017 Nov 24; 76():32-41. PubMed ID: 28987238
    [Abstract] [Full Text] [Related]

  • 8. Liver fat accumulation is associated with circulating PCSK9.
    Ruscica M, Ferri N, Macchi C, Meroni M, Lanti C, Ricci C, Maggioni M, Fracanzani AL, Badiali S, Fargion S, Magni P, Valenti L, Dongiovanni P.
    Ann Med; 2016 Aug 24; 48(5):384-91. PubMed ID: 27222915
    [Abstract] [Full Text] [Related]

  • 9. Direct contact between human peripheral blood mononuclear cells and renal fibroblasts facilitates the expression of monocyte chemoattractant protein-1.
    Hao L, Okada H, Kanno Y, Inoue T, Kobayashi T, Watanabe Y, Strutz F, Müller GA, Suzuki H.
    Am J Nephrol; 2003 Aug 24; 23(4):208-13. PubMed ID: 12771503
    [Abstract] [Full Text] [Related]

  • 10. Peripheral blood mononuclear cells as a potential source of biomarkers to test the efficacy of weight-loss strategies.
    Reynés B, Díaz-Rúa R, Cifre M, Oliver P, Palou A.
    Obesity (Silver Spring); 2015 Jan 24; 23(1):28-31. PubMed ID: 25294800
    [Abstract] [Full Text] [Related]

  • 11. The loss-of-function PCSK9 p.R46L genetic variant does not alter glucose homeostasis.
    Bonnefond A, Yengo L, Le May C, Fumeron F, Marre M, Balkau B, Charpentier G, Franc S, Froguel P, Cariou B, DESIR study group.
    Diabetologia; 2015 Sep 24; 58(9):2051-5. PubMed ID: 26049403
    [Abstract] [Full Text] [Related]

  • 12. Complexity of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants.
    Dron JS, Hegele RA.
    Curr Opin Lipidol; 2017 Apr 24; 28(2):161-169. PubMed ID: 28157721
    [Abstract] [Full Text] [Related]

  • 13. Enhanced pro-protein convertase subtilisin/kexin type 9 expression by C-reactive protein through p38MAPK-HNF1α pathway in HepG2 cells.
    Cui CJ, Li S, Zhu CG, Sun J, Du Y, Zhang Y, Wu NQ, Guo YL, Xu RX, Gao Y, Li JJ.
    J Cell Mol Med; 2016 Dec 24; 20(12):2374-2383. PubMed ID: 27633999
    [Abstract] [Full Text] [Related]

  • 14. PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver.
    Demers A, Samami S, Lauzier B, Des Rosiers C, Ngo Sock ET, Ong H, Mayer G.
    Arterioscler Thromb Vasc Biol; 2015 Dec 24; 35(12):2517-25. PubMed ID: 26494228
    [Abstract] [Full Text] [Related]

  • 15. Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia.
    Ohta N, Hori M, Takahashi A, Ogura M, Makino H, Tamanaha T, Fujiyama H, Miyamoto Y, Harada-Shiba M.
    J Clin Lipidol; 2016 Dec 24; 10(3):547-555.e5. PubMed ID: 27206942
    [Abstract] [Full Text] [Related]

  • 16. Naringin Activates AMPK Resulting in Altered Expression of SREBPs, PCSK9, and LDLR To Reduce Body Weight in Obese C57BL/6J Mice.
    Sui GG, Xiao HB, Lu XY, Sun ZL.
    J Agric Food Chem; 2018 Aug 29; 66(34):8983-8990. PubMed ID: 30092639
    [Abstract] [Full Text] [Related]

  • 17. Circulating proprotein convertase subtilisin/kexin 9 (PCSK9) regulates VLDLR protein and triglyceride accumulation in visceral adipose tissue.
    Roubtsova A, Munkonda MN, Awan Z, Marcinkiewicz J, Chamberland A, Lazure C, Cianflone K, Seidah NG, Prat A.
    Arterioscler Thromb Vasc Biol; 2011 Apr 29; 31(4):785-91. PubMed ID: 21273557
    [Abstract] [Full Text] [Related]

  • 18. [Protection of huanglian jiedu decoction on systemic and vascular immune responses of high fat induced apoE(-/-) mice].
    Ma YL, Wang BB, Han JY, Li R, Zhang WM, Li T, Chen B, Su J, Wang XB, Zeng H.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2013 Nov 29; 33(11):1520-5. PubMed ID: 24483114
    [Abstract] [Full Text] [Related]

  • 19. CD36 Is a Marker of Human Adipocyte Progenitors with Pronounced Adipogenic and Triglyceride Accumulation Potential.
    Gao H, Volat F, Sandhow L, Galitzky J, Nguyen T, Esteve D, Åström G, Mejhert N, Ledoux S, Thalamas C, Arner P, Guillemot JC, Qian H, Rydén M, Bouloumié A.
    Stem Cells; 2017 Jul 29; 35(7):1799-1814. PubMed ID: 28470788
    [Abstract] [Full Text] [Related]

  • 20. PCSK9 deficiency results in increased ectopic fat accumulation in experimental models and in humans.
    Baragetti A, Balzarotti G, Grigore L, Pellegatta F, Guerrini U, Pisano G, Fracanzani AL, Fargion S, Norata GD, Catapano AL.
    Eur J Prev Cardiol; 2017 Nov 29; 24(17):1870-1877. PubMed ID: 28758421
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.